EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The Combination of MIF Inhibitor and AEP Targeted Inhibitor to Reduce Lung Metastasis in Breast Cancer and Its Mechanism

Junsong Chen iD, Wenke Xu, Luyang Meng, Xin Zhang, Mengyao Lin, Sheng Zhang, Yi Liu, Fang Guo

Journal of Cellular and Molecular Medicine · 2025

DOI: 10.1111/jcmm.70616 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cellular and Molecular Medicine, 2025. Verfasst von Junsong Chen und 7 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Systems Biomedicine (Ministry of Education), Shanghai Center for Systems Biomedicine, Shanghai Jiao Tong University, Shanghai, Chin…. Hauptthemen laut MEDLINE: Lung Neoplasms, Breast Neoplasms, Macrophage Migration-Inhibitory Factors, Intramolecular Oxidoreductases. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The Fundamental Research Funds for the Central Universities, The Special Fund for Basic Scientific Research of Central Colleges, Shanghai Jiaotong University for Nationalities', the "111 Center".

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Breast cancer, the most prevalent malignant tumour in women, is characterised by high metastatic potential and frequent recurrence, both of which significantly impact patient prognosis following metastasis. To address this challenge, identifying novel therapeutic target combinations is critical for improving metastatic breast cancer treatment. This study investigates the mechanism by which asparaginyl endopeptidase (AEP) regulates breast cancer metastasis. Bioinformatics analysis revealed a potential interaction between AEP and CD74, which was subsequently confirmed through co‐immunoprecipitation (co‐IP) experiments. Further investigations demonstrated that AEP activates ERK pathway phosphorylation via CD74 regulation, thereby enhancing epithelial‐mesenchymal transition (EMT) progression and promoting breast cancer cell migration. Compared to controls, dual inhibition of AEP and CD74 effectively reduced EMT markers and the migratory capacity of cancer cells in vitro. Subsequent in vivo experiments showed that this combinatorial strategy significantly suppressed breast cancer lung metastasis in mice without observable toxicity. These findings elucidate the molecular mechanism through which AEP promotes metastasis via CD74 regulation, while validating the therapeutic efficacy and safety of dual AEP/CD74 targeting. This study provides a novel conceptual framework and potential therapeutic targets for metastatic breast cancer intervention.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lung NeoplasmsBreast NeoplasmsMacrophage Migration-Inhibitory FactorsIntramolecular OxidoreductasesHumansFemaleAnimalsEpithelial-Mesenchymal TransitionAntigens, Differentiation, B-LymphocyteCell Line, TumorCell MovementHistocompatibility Antigens Class IIMiceXenograft Model Antitumor AssaysMice, Inbred BALB CMice, NudeGene Expression Regulation, NeoplasticCysteine EndopeptidasesAsparaginyl Endopeptidase

Stichwörter der Autor:innen

CD74asparagine endopeptidasebreast cancerlung metastasismacrophage migration inhibitory factor

Substanzen

Antigens, Differentiation, B-LymphocyteHistocompatibility Antigens Class IIMacrophage Migration-Inhibitory FactorsIntramolecular OxidoreductasesCysteine EndopeptidasesAsparaginyl Endopeptidaseinvariant chainMIF protein, human

Autor:innen und Institutionen

  • Key Laboratory of Systems Biomedicine (Ministry of Education), Shanghai Center for Systems Biomedicine, Shanghai Jiao Tong University, Shanghai, China.
  • Department of Vascular Surgery, Hangzhou Third People's Hospital, Hangzhou, Zhejiang, China.
  • Department of Pathology, The First Affiliated Hospital of Fujian Medical University, Fuzhou, China.
  • Department of Radiotherapy, Huangpu Branch of the Ninth People's Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.

ORCID-Profile: Junsong Chen

Förderung

  • The Fundamental Research Funds for the Central Universities
  • The Special Fund for Basic Scientific Research of Central Colleges, Shanghai Jiaotong University for Nationalities'
  • the "111 Center"
  • Fundamental Research Funds for the Central Universities

Zitieren

APA

Chen, J., Xu, W., Meng, L., Zhang, X., Lin, M., Zhang, S., Liu, Y., & Guo, F. (2025). The Combination of MIF Inhibitor and AEP Targeted Inhibitor to Reduce Lung Metastasis in Breast Cancer and Its Mechanism. Journal of Cellular and Molecular Medicine. https://doi.org/10.1111/jcmm.70616

Vancouver

Chen J, Xu W, Meng L, Zhang X, Lin M, Zhang S, et al. The Combination of MIF Inhibitor and AEP Targeted Inhibitor to Reduce Lung Metastasis in Breast Cancer and Its Mechanism. Journal of Cellular and Molecular Medicine. 2025. doi:10.1111/jcmm.70616

BibTeX
@article{Chen2025,
  author = {Chen, Junsong and Xu, Wenke and Meng, Luyang and Zhang, Xin and Lin, Mengyao and Zhang, Sheng and Liu, Yi and Guo, Fang},
  title = {The Combination of MIF Inhibitor and AEP Targeted Inhibitor to Reduce Lung Metastasis in Breast Cancer and Its Mechanism},
  journal = {Journal of Cellular and Molecular Medicine},
  year = {2025},
  doi = {10.1111/jcmm.70616}
}
Kostenlos starten →